Report: Pharmacokinetic and drug interaction studies of Pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan
Journal Title: Pakistan Journal of Pharmaceutical Sciences - Year 2014, Vol 27, Issue 2
Abstract
Abstract: In the present study, the pharmacokinetic and drug interaction evaluation of two drugs pefloxacin and paracetamol was carried out by a single-dose, two-treatment and two-sequence crossover design. Total fifteen healthy volunteers participated out of which ten completed the study. All were male volunteers, aged 22.36 years (means), with a mean weight of 76.45±12.05 Kg. The washout period between treatments was 5 week. Initially the method utilized for quantitative analysis of the drug was developed which was further validated. The study involved plasma protein precipitation with ethyl acetate and detection was done at 275nm. The retention time for pefloxacin 18±1 min and paracetamol were approximately 6±1 min, respectively. The calibration curve for pefloxacin was linear in the concentration range of 0.125-12.0g/ml with r²=0.9987 in plasma. Standard concentration solution was maintained on the same temperature as that of volunteer’s samples to optimize the periods for the determination of drug concentration in the plasma samples. Blood samples were collected from volunteers at different time intervals. The pharmacokinetics and drug interaction studies were anticipated by plotting concentration versus time-profiles. The value of AUC0-∞ in control was 67.355±3.174µg.h/ml, in treatment 61.242±3.868µg.h/ml along with relative bioavailability =91.395±4.864. Under the control and treatment condition the mean maximum plasma concentrations were found to be 4.679±0.248 µg/ml and 4.6595±0.266 µg/ml respectively. The average Tmax for plasma concentrations was 1.819±0.1743hr and 1.605 ±0.1134hr respectively. The biological half-lives in the two phases of studies were found to be 7.953±0.33hr in control and 7.7257±0.355hr in treatment. No significant effect were observed on the bioavailability and pharmacokinetics of pefloxacin by the concomitant administration with paracetamol, however very minor effect were observed that might be related with inter-individual variation in human volunteers. This pharmacokinetic studies also indicated that the level of drug (Cmax) do not differ from previous studies in different races.
Authors and Affiliations
Shahnaz Gauhar , Syed Ayub Ali , Syed Baqir Naqvi , Muhammad Harris Shoaib
Keywords
Related Articles
- EP ID EP93955
- DOI -
- Views 62
- Downloads 0
Diverse pharmacological properties of Cinnamomum cassia: A review
Cinnamomum cassia is widely utilized as a spice in different cookeries worldwide, especially in Asian cuisines. This herb is also being used in different forms of traditional medicine (Unani, Ayurvedic, Japanese an...
Influences of Bushen Xingnao Decoction on expression of vascular endothelial growth factor, IL-1β and tumor necrosis factor-α in vascular dementia rats
To observe influences of Bushen Xingnao Decoction (BSXND) on expression of vascular endothelial growth factor (VEGF), IL-1β and tumor necrosis factor-α (TNF-α) in brain tissues and serum level of vascular dementia...
Prolonged oral cyanide effects on feed intake, growth rate and blood parameters in rabbits
Twelve adult rabbits bred locally were divided into two equal groups of 6; experimental and control groups. Rabbits in the experimental group were orally dosed with KCN at 3mg/kg body weight for 40 consecutive days...
Synergy of flavone with vancomycin and oxacillin against vancomycin-intermediate Staphylococcus aureus
This study evaluated in vitro activity of 9 flavonoids in combination with vancomycin or oxacillin against vancomycin-intermediate Staphylococcus aureus (VISA) ATCC 700699 by employing the checkerboard method to obtain M...
Plasmid borne BAC-IB17: Localization of a potential antibacterial positive marker (Bac+) encoded broad inhibitory spectrum bacteriocin[i][/i]
Production of antimicrobial compounds is considered as ubiquitous anti-competitor strategy in bacterial ecosystem. Bacteriocins are heterogeneous; highly specific and efficient anti-competitor agents and the gene r...